Cyclacel to Present at BIO Investor Forum

[at noodls] – BERKELEY HEIGHTS, N.J., Oct. 2, 2012 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that … more

View todays social media effects on CYCCP

View the latest stocks trending across Twitter. Click to view dashboard